IR-Med Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	0.03	0	0	0	0	0
Cost of Revenue	0.04	0.02	0.01	0.01	0	0
Gross Profit	-0.01	-0.02	-0.01	-0.01	-0	-0
Selling, General & Admin	2.56	2.83	2.74	2.18	0.32	0.15
Research & Development	1.65	2.06	1.89	1.42	0.41	0.06
Other Operating Expenses	0	0	0.14	0.07	0.01	0
Operating Expenses	4.21	4.89	4.76	3.68	0.73	0.21
Operating Income	-4.22	-4.91	-4.76	-3.68	-0.73	-0.21
Interest Income	-0	0	0	0	0	0
Interest Expense	0.02	0	0.01	0.01	0.01	0
Other Expense / Income	-0.02	-0	-0.03	0.04	0.01	0.03
Pretax Income	-4.22	-4.91	-4.73	-3.72	-0.75	-0.25
Income Tax	0	0	4.73	0.01	0.01	0
Net Income	-4.22	-4.91	-9.46	-3.72	-0.76	-0.25
Shares Outstanding (Basic)	70	69	68	63	30	29
Shares Outstanding (Diluted)	70	69	68	63	30	29
Shares Change	1.60%	2.70%	7.08%	110.14%	3.89%	-
EPS (Basic)	-0.06	-0.07	-0.14	-0.06	-0.03	-0.01
EPS (Diluted)	-0.06	-0.07	-0.14	-0.06	-0.03	-0.01
Free Cash Flow	-2.69	-3.23	-3.43	-2.51	-0.4	-0.07
Free Cash Flow Per Share	-0.04	-0.05	-0.05	-0.04	-0.01	-0.00
Gross Margin	-14.71%	-	-	-	-	-
Operating Margin	-12402.94%	-	-	-	-	-
Profit Margin	-12400.00%	-	-	-	-	-
Free Cash Flow Margin	-7917.65%	-	-	-	-	-
EBITDA	-4.2	-4.89	-4.75	-3.67	-0.73	-0.21
EBITDA Margin	-12338.24%	-	-	-	-	-
Depreciation & Amortization	0.02	0.02	0.01	0.01	0	0
EBIT	-4.22	-4.91	-4.76	-3.68	-0.73	-0.21
EBIT Margin	-12402.94%	-	-	-	-	-

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.